29 July 2020
Visiongain has launched a new report Patient Registry Software Market Report 2020-2030: Forecasts by Registry Type (Drugs, Diabetes, Cancer, Asthma, Orthopaedic), Software (Integrated, Standalone), Delivery (On-premise, Cloud), Functionality (Population Health Management, Patient Care Management, Health Information Exchange, Point-of-Care, Product Outcome Evaluation, Medical Research and Clinical Studies), Database (Commercial, Public), End-user (Government Organizations & Third-Party Administrators (TPAs), Hospitals and Medical Practices, Private Payers, Pharmaceutical & Biotechnology and Medical Device Companies, and Research Centers) and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
Patient registry software is mainly used to manage patient data regarding their disease condition and treatment. These solutions are also used to note the type of procedure conducted on the patient and the number of new medical devices used. These solutions also provide physicians real-time access to patient data and help improve patient outcome.
Patient registry solutions also collect the information regarding medication administered by the patient, which help in managing post-marketing information related to effectiveness and side-effects of any recently approved medication. Thus, patient registry software also helps to monitor and manage patient data undergoing clinical trials. The increase in R&D activities for clinical trials and growing importance of using these solutions to access data for new drug development are increasing its demand among pharmaceutical and biotechnology companies.
The rise in adoption of EHRs among the healthcare professionals, the initiative by government to build patient registries, and the increase in need to enhance quality of patient care are the major driving factors for the market growth. Furthermore, the increase in pressure to reduce healthcare costs, adoption of patient registry data for post-marketing surveillance, high adoption of subscription model, and introduction of cloud-based patient registry solutions also drives the growth of global patient registry software market. However, data safety concerns, lack of skilled healthcare IT professionals, and unwillingness to adopt advanced solutions among healthcare professionals can damper the growth of patient registry software market.
The Visiongain report analyst commented “the rise of use of patient registry software to track data regarding the effectiveness, safety and quality of new medication or medical device in the market is increasing the importance of these solutions for post-marketing surveillance among pharmaceutical, biotechnology, and medical devices companies. Furthermore, the increase in adoption of EHRs globally, government initiative to build national patient registries, and need to improve quality of patient care are driving the growth of the patient registry software market”.
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Global Vision Technologies, Inc., Dacima Software, Inc., FIGmd, Inc., CECity.com, Inc. (A Premier, Inc. Company), Liaison Technologies, Inc., ImageTrend, Inc., Phytel, Inc. (an IBM Corporation Company), Velos, Inc., INC Research Holdings, Inc., and Quintiles IMS Holdings, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global Biodefence market was valued at US$14,675.0 million in 2022 and is projected to grow at a CAGR of 7.78% during the forecast period 2023-2033.
13 January 2023
The global Neurotech Devices market was valued at US$11,582.1 million in 2022 and is projected to grow at a CAGR of 13.78% during the forecast period 2023-2033.
12 January 2023
The global Wearable Brain Devices market was valued at US$276.0 million in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period 2023-2033.
03 January 2023
The global Asthma & COPD Therapies market is estimated to be valued at US$47.85 billion in 2023 and is projected to grow at a CAGR of 7.31% during the forecast period 2023-2033.